Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11929543 | 1.00 | HRH3 (0.47) | HRH3CXCR4 | |
| SCHEMBL11929542 | 1.00 | HRH3 (0.47) | HRH3CXCR4 | |
| Bromide SCHEMBL27849072 | 0.98 | HRH3 (0.46) | HRH3CXCR4 | |
| Cyanide SCHEMBL30330583 | 0.94 | HRH3 (0.44) | HRH3CXCR4 | |
| SCHEMBL11922689 | 0.94 | CXCR4 (0.53) | HRH3CXCR4 | |
| SCHEMBL25824910 | 0.94 | CXCR4 (0.53) | HRH3CXCR4 | |
| SCHEMBL9491709 | 0.94 | S1PR1 (0.47) | HRH3CXCR4 | |
| SCHEMBL30598328 | 0.94 | CXCR4 (0.53) | HRH3CXCR4 | |
| SCHEMBL15363013 | 0.92 | S1PR1 (0.50) | HRH3CXCR4 | |
| SCHEMBL15363078 | 0.92 | S1PR1 (0.50) | HRH3CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113773529-B | Preparation method and application of photo-curing temperature-induced phase-change ionic gel electrolyte | 哈尔滨工业大学（深圳） | 2023-10-24 | — | — | CN | claimed |
| EP-3448917-B1 | METHODS FOR MAKING POLY(ARYL ETHER SULFONE) POLYMERS AND POLYMER COMPOSITIONS AND ARTICLES INCLUDING THE SAME | SOLVAY SPECIALTY POLYMERS USA (US) | 2021-12-01 | — | — | EP | claimed |
| CN-107108895-B | Process for the manufacture of poly (aryl ether) s using at least one organic base | 索尔维特殊聚合物美国有限责任公司 | 2020-10-16 | — | — | CN | claimed |
| US-10745522-B2 | Method for the manufacture of poly(aryl ethers) using at least one organic base | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2020-08-18 | — | — | US | claimed |
| EP-3209708-B1 | METHOD FOR THE MANUFACTURE OF POLY(ARYL ETHERS) USING AT LEAST ONE ORGANIC BASE | SOLVAY SPECIALTY POLYMERS USA L L C (US) | 2019-08-21 | — | — | EP | claimed |
| US-20190112428-A1 | METHODS FOR MAKING POLY(ARYL ETHER SULFONE) POLYMERS AND POLYMER COMPOSITIONS AND ARTICLES INCLUDING THE SAME | SOLVAY SPECIALITY POLYMERS USA, LLC | 2019-04-18 | — | — | US | claimed |
| CN-105378981-B | A kind of long-life, powerful lithium/sulphur battery improving battery performance using holistic approach | 加州大学校务委员会 | 2019-03-12 | — | — | CN | claimed |
| CN-104835953-B | Anatase TiO2The lithium ion battery material of admixed graphite alkene | 深圳市翔丰华科技股份有限公司 | 2018-07-13 | — | — | CN | claimed |
| US-20170355821-A1 | Method for the manufacture of poly(aryl ethers) using at least one organic base | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2017-12-14 | — | — | US | claimed |
| WO-2017186881-A1 | METHODS FOR MAKING POLY(ARYL ETHER SULFONE) POLYMERS AND POLYMER COMPOSITIONS AND ARTICLES INCLUDING THE SAME | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2017-11-02 | — | — | WO | claimed |
| EP-3209708-A1 | METHOD FOR THE MANUFACTURE OF POLY(ARYL ETHERS) USING AT LEAST ONE ORGANIC BASE | Solvay Specialty Polymers USA, L.L.C. (US) | 2017-08-30 | — | — | EP | claimed |
| CN-103682209-A | Composite membrane for lithium-air battery | DALIAN CHEMICAL PHYSICS INST | 2014-03-26 | — | — | CN | claimed |
| CN-116333346-B | Ionic gel for stretchable circuit and stretchable circuit board based on ionic gel | 中欧电子材料国际创新中心(合肥)有限公司 | 2025-08-29 | — | — | CN | disclosed |
| CN-116333346-A | Ionic gel for stretchable circuit and stretchable circuit board based on ionic gel | 中欧电子材料国际创新中心(合肥)有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116333346-A | Ionic gel for stretchable circuit and stretchable circuit board based on ionic gel | 中欧电子材料国际创新中心(合肥)有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-111995653-B | Preparation method of phytosterol/stanol ferulate | 江苏大学 | 2023-05-30 | — | — | CN | disclosed |
| US-20080188474-A1 | e.g. 1-phenyl-N3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1H-1,2,4-triazole-3,5-diamine; receptor protein tyrosine kinase (AXL) antagonist; antiinflammatory, anticarcinogenic , antidiabetic agent; rheumatoid arthritis, vascular disease; breast, renal, endometrial, ovarian carcinoma, or myeloid leukemia | RIGEL PHARMACEUTICALS, INC. (US) | 2008-08-07 | — | — | US | disclosed |
| CN-1950970-A | Material for electrolytic solution, ionic material-containing composition and use thereof | NIPPON CATALYTIC CHEM IND (JP) | 2007-04-18 | — | — | CN | disclosed |
| CN-1759497-A | Energy storage devices | COMMW SCIENT IND RES ORG (AU) | 2006-04-12 | — | — | CN | disclosed |
| US-20040248899-A1 | Fused bicyclic-substituted amines as histamine-3 receptor ligands | ABBVIE INC. | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248899-A1 | Fused bicyclic-substituted amines as histamine-3 receptor ligands | HRH3, HRH4, HRH1 | HRH3 1/4885CXCR4 667/4885 |
| US-20080188474-A1 | e.g. 1-phenyl-N3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1H-1,2,4-triazole-3,5-diamine; receptor protein tyrosine kinase (AXL) antagonist; antiinflammatory, anticarcinogenic , antidiabetic agent; rheumatoid arthritis, vascular disease; breast, renal, endometrial, ovarian carcinoma, or myeloid leukemia | AXL, TYRO3, FLT3 | HRH3 1213/4885CXCR4 1118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.